Investor Type | Firm |
Industries | BioTech • FinTech (& Financials services) |
Investing | Russia |
Medme is a venture capital firm established in 2014 with a dedicated focus on nurturing and investing in innovative startups within the BioTech, FinTech, and broader Financial Services sectors. They primarily target early-stage companies that are spearheading advances in information technology as it interfaces with healthcare and medicine. As pioneers seeking to bridge the gap between groundbreaking technology and practical applications in these critical industries, Medme believes in the transformative power of startups and the potential they hold in shaping the future of healthcare and financial services. Their investment thesis revolves around identifying and supporting visionary entrepreneurs who demonstrate the potential to disrupt existing markets, introduce efficiencies, and create new opportunities through technological innovation. Medme's methodology involves not just the provision of financial resources but also strategic guidance to nurture the growth of their portfolio companies. The fund leverages its expertise and network within the BioTech and FinTech landscapes to empower founders and their teams, helping them to scale their operations and realize their full market potential. With a commitment to fostering advancements that have a meaningful impact, Medme employs a hands-on approach, ensuring that the startups they invest in are equipped with the tools and knowledge necessary for long-term success.